AML patients with a higher percentageof CD34+ cells had a similarly, and significantly,higherFAMLF-CS expression compared with those patients with lowerCD34+ expression (P=0.041, Table3), but this significant difference was not found in the ALL group(P=0.905, Table 3). The gene discussed is CS; the disease is acute lymphoblastic leukemia.